nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—lung cancer	0.647	1	CbGaD
Tafluprost—PTGS2—Cisplatin—lung cancer	0.0837	0.504	CbGbCtD
Tafluprost—PTGS2—Etoposide—lung cancer	0.0823	0.496	CbGbCtD
Tafluprost—Ocular hyperaemia—Gefitinib—lung cancer	0.00569	0.0691	CcSEcCtD
Tafluprost—Visual acuity reduced—Crizotinib—lung cancer	0.00494	0.06	CcSEcCtD
Tafluprost—Uveitis—Erlotinib—lung cancer	0.00456	0.0555	CcSEcCtD
Tafluprost—Dinoprost Tromethamine—HPGDS—lung cancer	0.00351	1	CrCbGaD
Tafluprost—PTGFR—respiratory system—lung cancer	0.00327	0.209	CbGeAlD
Tafluprost—Lacrimation increased—Pemetrexed—lung cancer	0.00291	0.0354	CcSEcCtD
Tafluprost—Photophobia—Crizotinib—lung cancer	0.00276	0.0335	CcSEcCtD
Tafluprost—PTGFR—bronchus—lung cancer	0.00269	0.172	CbGeAlD
Tafluprost—Dry eye—Gefitinib—lung cancer	0.00246	0.0299	CcSEcCtD
Tafluprost—PTGFR—trachea—lung cancer	0.00242	0.154	CbGeAlD
Tafluprost—Eye pain—Gefitinib—lung cancer	0.00214	0.0261	CcSEcCtD
Tafluprost—Eye pruritus—Paclitaxel—lung cancer	0.00207	0.0252	CcSEcCtD
Tafluprost—PTGFR—lung—lung cancer	0.00174	0.111	CbGeAlD
Tafluprost—Visual acuity reduced—Paclitaxel—lung cancer	0.00156	0.0189	CcSEcCtD
Tafluprost—Photophobia—Vinblastine—lung cancer	0.00156	0.0189	CcSEcCtD
Tafluprost—Dry eye—Erlotinib—lung cancer	0.00147	0.0179	CcSEcCtD
Tafluprost—Eye disorder—Crizotinib—lung cancer	0.00138	0.0168	CcSEcCtD
Tafluprost—Eye disorder—Pemetrexed—lung cancer	0.00126	0.0153	CcSEcCtD
Tafluprost—Eye disorder—Gefitinib—lung cancer	0.00125	0.0152	CcSEcCtD
Tafluprost—Lacrimation increased—Irinotecan—lung cancer	0.00123	0.015	CcSEcCtD
Tafluprost—Vision blurred—Crizotinib—lung cancer	0.00121	0.0147	CcSEcCtD
Tafluprost—PTGFR—lymph node—lung cancer	0.00119	0.0757	CbGeAlD
Tafluprost—Eye irritation—Paclitaxel—lung cancer	0.00109	0.0132	CcSEcCtD
Tafluprost—Nervous system disorder—Crizotinib—lung cancer	0.00103	0.0125	CcSEcCtD
Tafluprost—Cough—Gefitinib—lung cancer	0.00102	0.0124	CcSEcCtD
Tafluprost—Lacrimation increased—Paclitaxel—lung cancer	0.00101	0.0122	CcSEcCtD
Tafluprost—Nervous system disorder—Pemetrexed—lung cancer	0.000939	0.0114	CcSEcCtD
Tafluprost—Dyspnoea—Crizotinib—lung cancer	0.000934	0.0114	CcSEcCtD
Tafluprost—Nervous system disorder—Gefitinib—lung cancer	0.000933	0.0113	CcSEcCtD
Tafluprost—Eye irritation—Docetaxel—lung cancer	0.00092	0.0112	CcSEcCtD
Tafluprost—PTGS2—respiratory system—lung cancer	0.000898	0.0573	CbGeAlD
Tafluprost—Dry eye—Paclitaxel—lung cancer	0.000856	0.0104	CcSEcCtD
Tafluprost—Dyspnoea—Pemetrexed—lung cancer	0.000854	0.0104	CcSEcCtD
Tafluprost—Lacrimation increased—Docetaxel—lung cancer	0.000853	0.0104	CcSEcCtD
Tafluprost—Dyspnoea—Gefitinib—lung cancer	0.000848	0.0103	CcSEcCtD
Tafluprost—Rhinitis—Topotecan—lung cancer	0.000811	0.00986	CcSEcCtD
Tafluprost—PTGS2—epithelium—lung cancer	0.000751	0.0479	CbGeAlD
Tafluprost—Eye disorder—Erlotinib—lung cancer	0.000748	0.00909	CcSEcCtD
Tafluprost—Eye pain—Paclitaxel—lung cancer	0.000745	0.00906	CcSEcCtD
Tafluprost—PTGS2—bronchus—lung cancer	0.000739	0.0472	CbGeAlD
Tafluprost—Dyspnoea—Teniposide—lung cancer	0.000691	0.00841	CcSEcCtD
Tafluprost—Pruritus—Pemetrexed—lung cancer	0.000677	0.00824	CcSEcCtD
Tafluprost—Pruritus—Gefitinib—lung cancer	0.000673	0.00818	CcSEcCtD
Tafluprost—Nasopharyngitis—Cisplatin—lung cancer	0.00067	0.00814	CcSEcCtD
Tafluprost—PTGS2—trachea—lung cancer	0.000664	0.0423	CbGeAlD
Tafluprost—Cough—Topotecan—lung cancer	0.000615	0.00747	CcSEcCtD
Tafluprost—Cough—Erlotinib—lung cancer	0.000608	0.00739	CcSEcCtD
Tafluprost—Nasopharyngitis—Paclitaxel—lung cancer	0.000602	0.00732	CcSEcCtD
Tafluprost—Rhinitis—Irinotecan—lung cancer	0.000572	0.00696	CcSEcCtD
Tafluprost—Nervous system disorder—Topotecan—lung cancer	0.000564	0.00685	CcSEcCtD
Tafluprost—Nervous system disorder—Erlotinib—lung cancer	0.000558	0.00678	CcSEcCtD
Tafluprost—Rhinitis—Gemcitabine—lung cancer	0.000557	0.00678	CcSEcCtD
Tafluprost—Pruritus—Teniposide—lung cancer	0.000549	0.00667	CcSEcCtD
Tafluprost—Lacrimation increased—Doxorubicin—lung cancer	0.000532	0.00647	CcSEcCtD
Tafluprost—PTGS2—bone marrow—lung cancer	0.000527	0.0336	CbGeAlD
Tafluprost—Cough—Vinorelbine—lung cancer	0.000526	0.00639	CcSEcCtD
Tafluprost—Dyspnoea—Topotecan—lung cancer	0.000512	0.00623	CcSEcCtD
Tafluprost—Nasopharyngitis—Docetaxel—lung cancer	0.00051	0.0062	CcSEcCtD
Tafluprost—Dyspnoea—Erlotinib—lung cancer	0.000507	0.00616	CcSEcCtD
Tafluprost—Urinary tract infection—Paclitaxel—lung cancer	0.000504	0.00613	CcSEcCtD
Tafluprost—Headache—Teniposide—lung cancer	0.000486	0.00591	CcSEcCtD
Tafluprost—Eye disorder—Cisplatin—lung cancer	0.000484	0.00589	CcSEcCtD
Tafluprost—Nervous system disorder—Vinorelbine—lung cancer	0.000482	0.00586	CcSEcCtD
Tafluprost—PTGS2—lung—lung cancer	0.000477	0.0304	CbGeAlD
Tafluprost—Rhinitis—Paclitaxel—lung cancer	0.000467	0.00567	CcSEcCtD
Tafluprost—Dry eye—Doxorubicin—lung cancer	0.000453	0.00551	CcSEcCtD
Tafluprost—Eye disorder—Etoposide—lung cancer	0.000444	0.00539	CcSEcCtD
Tafluprost—Dyspnoea—Vinorelbine—lung cancer	0.000438	0.00533	CcSEcCtD
Tafluprost—Eye disorder—Paclitaxel—lung cancer	0.000435	0.00529	CcSEcCtD
Tafluprost—Cough—Irinotecan—lung cancer	0.000434	0.00527	CcSEcCtD
Tafluprost—Vision blurred—Cisplatin—lung cancer	0.000425	0.00517	CcSEcCtD
Tafluprost—Cough—Gemcitabine—lung cancer	0.000422	0.00513	CcSEcCtD
Tafluprost—Pruritus—Topotecan—lung cancer	0.000407	0.00494	CcSEcCtD
Tafluprost—Pruritus—Erlotinib—lung cancer	0.000402	0.00489	CcSEcCtD
Tafluprost—Nervous system disorder—Irinotecan—lung cancer	0.000398	0.00483	CcSEcCtD
Tafluprost—Rhinitis—Docetaxel—lung cancer	0.000396	0.00481	CcSEcCtD
Tafluprost—Eye pain—Doxorubicin—lung cancer	0.000394	0.00479	CcSEcCtD
Tafluprost—Nervous system disorder—Gemcitabine—lung cancer	0.000387	0.00471	CcSEcCtD
Tafluprost—Vision blurred—Paclitaxel—lung cancer	0.000382	0.00464	CcSEcCtD
Tafluprost—Headache—Vinblastine—lung cancer	0.000371	0.00451	CcSEcCtD
Tafluprost—Eye disorder—Docetaxel—lung cancer	0.000369	0.00448	CcSEcCtD
Tafluprost—Dyspnoea—Irinotecan—lung cancer	0.000362	0.0044	CcSEcCtD
Tafluprost—Nervous system disorder—Cisplatin—lung cancer	0.000361	0.00439	CcSEcCtD
Tafluprost—Cough—Etoposide—lung cancer	0.000361	0.00438	CcSEcCtD
Tafluprost—Headache—Topotecan—lung cancer	0.00036	0.00438	CcSEcCtD
Tafluprost—Headache—Erlotinib—lung cancer	0.000356	0.00433	CcSEcCtD
Tafluprost—Asthma—Methotrexate—lung cancer	0.000355	0.00432	CcSEcCtD
Tafluprost—Cough—Paclitaxel—lung cancer	0.000354	0.0043	CcSEcCtD
Tafluprost—Dyspnoea—Gemcitabine—lung cancer	0.000352	0.00428	CcSEcCtD
Tafluprost—Pruritus—Vinorelbine—lung cancer	0.000348	0.00423	CcSEcCtD
Tafluprost—Dyspnoea—Cisplatin—lung cancer	0.000328	0.00399	CcSEcCtD
Tafluprost—PTGS2—lymph node—lung cancer	0.000326	0.0208	CbGeAlD
Tafluprost—Nervous system disorder—Paclitaxel—lung cancer	0.000324	0.00394	CcSEcCtD
Tafluprost—Nasopharyngitis—Doxorubicin—lung cancer	0.000318	0.00387	CcSEcCtD
Tafluprost—Headache—Vinorelbine—lung cancer	0.000308	0.00374	CcSEcCtD
Tafluprost—Asthma—Doxorubicin—lung cancer	0.000308	0.00374	CcSEcCtD
Tafluprost—Dyspnoea—Etoposide—lung cancer	0.000301	0.00366	CcSEcCtD
Tafluprost—Cough—Docetaxel—lung cancer	0.0003	0.00364	CcSEcCtD
Tafluprost—Dyspnoea—Paclitaxel—lung cancer	0.000295	0.00358	CcSEcCtD
Tafluprost—Pruritus—Gemcitabine—lung cancer	0.000279	0.0034	CcSEcCtD
Tafluprost—Nervous system disorder—Docetaxel—lung cancer	0.000275	0.00334	CcSEcCtD
Tafluprost—Urinary tract infection—Doxorubicin—lung cancer	0.000267	0.00324	CcSEcCtD
Tafluprost—Eye disorder—Methotrexate—lung cancer	0.000266	0.00323	CcSEcCtD
Tafluprost—Headache—Irinotecan—lung cancer	0.000254	0.00309	CcSEcCtD
Tafluprost—Dyspnoea—Docetaxel—lung cancer	0.00025	0.00304	CcSEcCtD
Tafluprost—Headache—Gemcitabine—lung cancer	0.000247	0.00301	CcSEcCtD
Tafluprost—Rhinitis—Doxorubicin—lung cancer	0.000247	0.003	CcSEcCtD
Tafluprost—Pruritus—Etoposide—lung cancer	0.000239	0.0029	CcSEcCtD
Tafluprost—Pruritus—Paclitaxel—lung cancer	0.000234	0.00284	CcSEcCtD
Tafluprost—Vision blurred—Methotrexate—lung cancer	0.000233	0.00284	CcSEcCtD
Tafluprost—Eye disorder—Doxorubicin—lung cancer	0.00023	0.0028	CcSEcCtD
Tafluprost—Cough—Methotrexate—lung cancer	0.000216	0.00263	CcSEcCtD
Tafluprost—Headache—Etoposide—lung cancer	0.000211	0.00257	CcSEcCtD
Tafluprost—Headache—Paclitaxel—lung cancer	0.000207	0.00252	CcSEcCtD
Tafluprost—Vision blurred—Doxorubicin—lung cancer	0.000202	0.00246	CcSEcCtD
Tafluprost—Pruritus—Docetaxel—lung cancer	0.000198	0.00241	CcSEcCtD
Tafluprost—Nervous system disorder—Methotrexate—lung cancer	0.000198	0.00241	CcSEcCtD
Tafluprost—Cough—Doxorubicin—lung cancer	0.000187	0.00227	CcSEcCtD
Tafluprost—Dyspnoea—Methotrexate—lung cancer	0.00018	0.00219	CcSEcCtD
Tafluprost—Headache—Docetaxel—lung cancer	0.000176	0.00214	CcSEcCtD
Tafluprost—Nervous system disorder—Doxorubicin—lung cancer	0.000172	0.00209	CcSEcCtD
Tafluprost—Dyspnoea—Doxorubicin—lung cancer	0.000156	0.0019	CcSEcCtD
Tafluprost—Pruritus—Methotrexate—lung cancer	0.000143	0.00174	CcSEcCtD
Tafluprost—Headache—Methotrexate—lung cancer	0.000127	0.00154	CcSEcCtD
Tafluprost—Pruritus—Doxorubicin—lung cancer	0.000124	0.0015	CcSEcCtD
Tafluprost—PTGS2—C-MYB transcription factor network—EP300—lung cancer	0.000123	0.00144	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000121	0.00142	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNG11—lung cancer	0.000119	0.00139	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—lung cancer	0.000117	0.00136	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AVP—lung cancer	0.000116	0.00136	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000116	0.00136	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000116	0.00136	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—NRAS—lung cancer	0.000115	0.00134	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000115	0.00134	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFC—lung cancer	0.000113	0.00132	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000111	0.0013	CbGpPWpGaD
Tafluprost—Headache—Doxorubicin—lung cancer	0.00011	0.00133	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—lung cancer	0.000109	0.00128	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MYC—lung cancer	0.000107	0.00125	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADCY1—lung cancer	0.000107	0.00125	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ATP5H—lung cancer	0.000105	0.00122	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—lung cancer	0.000104	0.00122	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—lung cancer	0.000104	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PPP2R1B—lung cancer	0.000104	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SMARCA4—lung cancer	0.000104	0.00122	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCND1—lung cancer	0.000102	0.00119	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000101	0.00118	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HSPB1—lung cancer	0.0001	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	9.96e-05	0.00117	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTHLH—lung cancer	9.92e-05	0.00116	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—KRAS—lung cancer	9.88e-05	0.00116	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—lung cancer	9.87e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	9.62e-05	0.00112	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	9.39e-05	0.0011	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	9.34e-05	0.00109	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ANXA1—lung cancer	9.33e-05	0.00109	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLBD1—lung cancer	9.33e-05	0.00109	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	9.17e-05	0.00107	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FLT1—lung cancer	9.04e-05	0.00106	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CG—lung cancer	8.95e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	8.92e-05	0.00104	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APP—lung cancer	8.84e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH3—lung cancer	8.84e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF9—lung cancer	8.77e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSD17B10—lung cancer	8.53e-05	0.000998	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—POMC—lung cancer	8.52e-05	0.000997	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PGAM1—lung cancer	8.44e-05	0.000987	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—HRAS—lung cancer	8.4e-05	0.000983	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MAPK3—lung cancer	8.38e-05	0.00098	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUNB—lung cancer	8.38e-05	0.00098	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MYC—lung cancer	8.15e-05	0.000954	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CG—lung cancer	8.13e-05	0.000951	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EGFR—lung cancer	7.97e-05	0.000933	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	7.94e-05	0.000928	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CKB—lung cancer	7.93e-05	0.000928	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	7.91e-05	0.000925	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SDC4—lung cancer	7.88e-05	0.000922	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CD—lung cancer	7.87e-05	0.000921	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	7.82e-05	0.000915	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—lung cancer	7.75e-05	0.000906	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—POMC—lung cancer	7.74e-05	0.000905	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STK11—lung cancer	7.61e-05	0.00089	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6R—lung cancer	7.55e-05	0.000883	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CNDP2—lung cancer	7.46e-05	0.000872	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM2—lung cancer	7.46e-05	0.000872	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FOXO3—lung cancer	7.34e-05	0.000859	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTMR3—lung cancer	7.25e-05	0.000848	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAP2K1—lung cancer	7.19e-05	0.000842	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CD—lung cancer	7.15e-05	0.000836	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	7.1e-05	0.000831	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PGAM1—lung cancer	7.07e-05	0.000827	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SKI—lung cancer	6.95e-05	0.000813	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	6.91e-05	0.000809	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	6.9e-05	0.000807	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AVP—lung cancer	6.88e-05	0.000805	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CB—lung cancer	6.86e-05	0.000802	CbGpPWpGaD
Tafluprost—PTGS2—Disease—B4GALT5—lung cancer	6.75e-05	0.000789	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2A7—lung cancer	6.74e-05	0.000789	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—lung cancer	6.69e-05	0.000783	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	6.69e-05	0.000782	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	6.67e-05	0.000781	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF1R—lung cancer	6.62e-05	0.000775	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SDC4—lung cancer	6.6e-05	0.000772	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—lung cancer	6.59e-05	0.000771	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HES1—lung cancer	6.5e-05	0.000761	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RAF1—lung cancer	6.38e-05	0.000746	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	6.36e-05	0.000744	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—lung cancer	6.3e-05	0.000737	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CB—lung cancer	6.23e-05	0.000729	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.19e-05	0.000724	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—lung cancer	6.13e-05	0.000717	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PXN—lung cancer	6.04e-05	0.000706	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.03e-05	0.000705	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—RRM1—lung cancer	6.01e-05	0.000703	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA3—lung cancer	6.01e-05	0.000703	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—lung cancer	5.99e-05	0.0007	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ERBB3—lung cancer	5.95e-05	0.000696	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKR1C1—lung cancer	5.91e-05	0.000691	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—lung cancer	5.72e-05	0.000669	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	5.7e-05	0.000667	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TERT—lung cancer	5.7e-05	0.000667	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—B4GALT5—lung cancer	5.65e-05	0.000661	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	5.54e-05	0.000649	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGFR1—lung cancer	5.53e-05	0.000647	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA4—lung cancer	5.5e-05	0.000643	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HIF1A—lung cancer	5.45e-05	0.000638	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NPPA—lung cancer	5.44e-05	0.000636	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.42e-05	0.000634	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.37e-05	0.000628	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA2—lung cancer	5.36e-05	0.000627	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPIA—lung cancer	5.31e-05	0.000621	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ALDOA—lung cancer	5.27e-05	0.000616	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOA1—lung cancer	5.26e-05	0.000615	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KDR—lung cancer	5.21e-05	0.00061	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA1—lung cancer	5.17e-05	0.000605	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.12e-05	0.000599	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCC3—lung cancer	5.11e-05	0.000598	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADCY1—lung cancer	4.97e-05	0.000582	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKR1C1—lung cancer	4.95e-05	0.000579	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ENO2—lung cancer	4.88e-05	0.000571	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPP2R1B—lung cancer	4.85e-05	0.000567	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SMARCA4—lung cancer	4.85e-05	0.000567	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UGT1A1—lung cancer	4.8e-05	0.000562	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KIT—lung cancer	4.8e-05	0.000562	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CG—lung cancer	4.8e-05	0.000562	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APC—lung cancer	4.8e-05	0.000562	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NRAS—lung cancer	4.8e-05	0.000562	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGF—lung cancer	4.75e-05	0.000555	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.71e-05	0.000551	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GNG11—lung cancer	4.63e-05	0.000542	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.61e-05	0.000539	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAPK3—lung cancer	4.6e-05	0.000538	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—POMC—lung cancer	4.57e-05	0.000535	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.55e-05	0.000533	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BRAF—lung cancer	4.51e-05	0.000528	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6R—lung cancer	4.46e-05	0.000522	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CREBBP—lung cancer	4.45e-05	0.000521	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ENO1—lung cancer	4.43e-05	0.000519	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDOA—lung cancer	4.41e-05	0.000516	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EGFR—lung cancer	4.37e-05	0.000512	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOA3—lung cancer	4.28e-05	0.000501	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAP2K1—lung cancer	4.25e-05	0.000497	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CD—lung cancer	4.22e-05	0.000494	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.21e-05	0.000492	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—lung cancer	4.18e-05	0.000489	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADCY1—lung cancer	4.17e-05	0.000487	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCG2—lung cancer	4.17e-05	0.000487	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—lung cancer	4.13e-05	0.000483	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APP—lung cancer	4.12e-05	0.000482	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF9—lung cancer	4.09e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENO2—lung cancer	4.09e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HPGDS—lung cancer	4.09e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPP2R1B—lung cancer	4.06e-05	0.000475	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.01e-05	0.000469	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTT1—lung cancer	3.96e-05	0.000464	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCLC—lung cancer	3.92e-05	0.000458	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2A6—lung cancer	3.92e-05	0.000458	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JUNB—lung cancer	3.9e-05	0.000457	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.9e-05	0.000456	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.85e-05	0.00045	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—lung cancer	3.8e-05	0.000444	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MDM2—lung cancer	3.78e-05	0.000442	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RAF1—lung cancer	3.77e-05	0.000441	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ERBB2—lung cancer	3.73e-05	0.000436	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENO1—lung cancer	3.71e-05	0.000434	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.7e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CB—lung cancer	3.68e-05	0.00043	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MTOR—lung cancer	3.68e-05	0.00043	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.65e-05	0.000427	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—lung cancer	3.54e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HRAS—lung cancer	3.51e-05	0.000411	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FOXO3—lung cancer	3.42e-05	0.0004	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—lung cancer	3.42e-05	0.0004	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—lung cancer	3.38e-05	0.000396	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—lung cancer	3.38e-05	0.000395	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—lung cancer	3.36e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2E1—lung cancer	3.33e-05	0.00039	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCND1—lung cancer	3.29e-05	0.000385	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NQO1—lung cancer	3.29e-05	0.000385	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUN—lung cancer	3.29e-05	0.000385	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.22e-05	0.000377	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—lung cancer	3.2e-05	0.000374	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1A—lung cancer	3.19e-05	0.000373	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTEN—lung cancer	3.18e-05	0.000372	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—lung cancer	3.1e-05	0.000363	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EP300—lung cancer	3.03e-05	0.000355	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HES1—lung cancer	3.03e-05	0.000355	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—STK11—lung cancer	2.97e-05	0.000347	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SRC—lung cancer	2.95e-05	0.000345	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—lung cancer	2.87e-05	0.000336	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—lung cancer	2.84e-05	0.000333	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NRAS—lung cancer	2.84e-05	0.000332	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERCC2—lung cancer	2.83e-05	0.000331	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.79e-05	0.000326	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERBB3—lung cancer	2.77e-05	0.000324	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTP1—lung cancer	2.75e-05	0.000321	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK3—lung cancer	2.72e-05	0.000318	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAT—lung cancer	2.67e-05	0.000313	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.66e-05	0.000311	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TERT—lung cancer	2.66e-05	0.000311	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—lung cancer	2.64e-05	0.000309	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCB1—lung cancer	2.6e-05	0.000304	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGFR—lung cancer	2.58e-05	0.000302	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGFR1—lung cancer	2.58e-05	0.000302	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TYMS—lung cancer	2.55e-05	0.000299	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HIF1A—lung cancer	2.54e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM1—lung cancer	2.52e-05	0.000295	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOA1—lung cancer	2.45e-05	0.000287	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—lung cancer	2.44e-05	0.000286	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP1A1—lung cancer	2.39e-05	0.00028	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ERCC2—lung cancer	2.37e-05	0.000278	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—lung cancer	2.24e-05	0.000262	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KIT—lung cancer	2.24e-05	0.000262	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APC—lung cancer	2.24e-05	0.000262	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGF—lung cancer	2.21e-05	0.000259	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—lung cancer	2.17e-05	0.000254	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BRAF—lung cancer	2.1e-05	0.000246	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6R—lung cancer	2.08e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRAS—lung cancer	2.08e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CREBBP—lung cancer	2.07e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOA1—lung cancer	2.05e-05	0.00024	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—lung cancer	1.99e-05	0.000232	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAP2K1—lung cancer	1.98e-05	0.000232	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CD—lung cancer	1.97e-05	0.00023	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.97e-05	0.00023	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CG—lung cancer	1.87e-05	0.000219	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—lung cancer	1.83e-05	0.000214	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—POMC—lung cancer	1.78e-05	0.000209	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MDM2—lung cancer	1.76e-05	0.000206	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RAF1—lung cancer	1.76e-05	0.000205	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CREBBP—lung cancer	1.74e-05	0.000203	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERBB2—lung cancer	1.74e-05	0.000203	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CB—lung cancer	1.71e-05	0.000201	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTOR—lung cancer	1.71e-05	0.000201	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—lung cancer	1.71e-05	0.0002	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CD—lung cancer	1.65e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—lung cancer	1.63e-05	0.00019	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1A—lung cancer	1.48e-05	0.000174	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PTEN—lung cancer	1.48e-05	0.000173	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CB—lung cancer	1.44e-05	0.000168	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EP300—lung cancer	1.41e-05	0.000165	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SRC—lung cancer	1.37e-05	0.000161	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—lung cancer	1.33e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NRAS—lung cancer	1.32e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAPK3—lung cancer	1.27e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTEN—lung cancer	1.24e-05	0.000145	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—lung cancer	1.23e-05	0.000144	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGFR—lung cancer	1.2e-05	0.000141	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—EP300—lung cancer	1.18e-05	0.000138	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—lung cancer	1.14e-05	0.000133	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—lung cancer	1.05e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HRAS—lung cancer	9.67e-06	0.000113	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—lung cancer	9.26e-06	0.000108	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—lung cancer	8.75e-06	0.000102	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—lung cancer	8.54e-06	9.99e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—lung cancer	7.15e-06	8.37e-05	CbGpPWpGaD
